Category: Life Sciences
Global Life Sciences
-
Endometrial Ablation Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More
-
Healthcare Cleanroom Consumables
... at a CAGR of 4.8% over the analysis period 2024-2030. Cleanroom Apparels, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.7 Billion by the end of ... Read More
-
Healthcare Information Systems
... at a CAGR of 11.4% over the analysis period 2024-2030. Web-based, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$396.5 Billion by the end of the ... Read More
-
Interferon
... 2.8% over the analysis period 2024-2030. Interferon Beta, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth ... Read More
-
Acne Drugs
... CAGR of 6.9% over the analysis period 2024-2030. Inflammatory, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$9.6 Billion by the end of the analysis period. ... Read More
-
Aesthetic Medicine
... CAGR of 10.0% over the analysis period 2024-2030. Invasive, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$90.4 Billion by the end of the analysis period. ... Read More
-
Microwave Ablation
... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the analysis ... Read More
-
Vancomycin
... 4.9% over the analysis period 2024-2030. Lung Infection, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. Growth ... Read More
-
Venturi Masks
... CAGR of 11.5% over the analysis period 2024-2030. COPD, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of the analysis period. ... Read More
-
Allografts
... 6.9% over the analysis period 2024-2030. Demineralized Bone Matrix (DBM), one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$488.4 Million by the end of the analysis ... Read More
-
Enteral Feeding Pumps
... at a CAGR of 6.0% over the analysis period 2024-2030. Neurological Disorders, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$751.7 Million by the end of ... Read More
-
Tonometers
... 4.1% over the analysis period 2024-2030. Applanation Tonometer, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$157.4 Million by the end of the analysis period. Growth ... Read More
-
Veterinary Electrosurgery
... CAGR of 8.6% over the analysis period 2024-2030. Bipolar Electrosurgery Instruments, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$74.4 Million by the end of the ... Read More
-
Patient Positioning Systems
... at a CAGR of 4.8% over the analysis period 2024-2030. Tables, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Surgical Gloves
... CAGR of 5.9% over the analysis period 2024-2030. Latex Gloves, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More
-
Vendor Neutral Archives
... at a CAGR of 6.5% over the analysis period 2024-2030. On-Premises, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$552.5 Million by the end of the ... Read More
-
Accountable Care Solutions
... at a CAGR of 18.4% over the analysis period 2024-2030. Healthcare Provider Solutions, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$62.7 Billion by the end ... Read More
-
Antisense and RNAi Therapeutics
... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Antisense RNA, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.8 Billion by the ... Read More
-
Blood Group Typing
... at a CAGR of 9.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$2.8 Billion by the end of the ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
-
Bronchodilators
... 4.6% over the analysis period 2024-2030. Asthma, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$19.1 Billion by the end of the analysis period. Growth in ... Read More
-
Disposable Respirators
... CAGR of 4.5% over the analysis period 2024-2030. N-Series, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More
-
Animal Proteins
... CAGR of 6.9% over the analysis period 2024-2030. Food & Beverage, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Care Management Solutions
... at a CAGR of 10.3% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$26.4 Billion by the end of the ... Read More
Research Assistance
